Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Get Free Trial
Send Info
Initiation
Prelude Therapeutics initiated with bullish view at JMP Securities, here's why » 04:49
03/13/24
03/13
04:49
03/13/24
04:49
PRLD

Prelude Therapeutics

$4.11 /

-0.025 (-0.60%)

JMP Securities initiated…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Downgrade
Prelude Therapeutics just downgraded at H.C. Wainwright, here's why » 06:08
02/20/24
02/20
06:08
02/20/24
06:08
PRLD

Prelude Therapeutics

$4.60 /

+1.13 (+32.56%)

H.C. Wainwright analyst…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Syndicate
Prelude Therapeutics files to sell 7.94M shares of common stock for holders 06:02
02/16/24
02/16
06:02
02/16/24
06:02
PRLD

Prelude Therapeutics

$3.47 /

+0.06 (+1.76%)

 
Over a quarter ago
Downgrade
Prelude Therapeutics just downgraded at Morgan Stanley, here's why » 07:09
12/19/23
12/19
07:09
12/19/23
07:09
PRLD

Prelude Therapeutics

$4.37 /

+0.025 (+0.58%)

Morgan Stanley downgraded…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Prelude Therapeutics price target lowered to $5 from $6 at H.C. Wainwright » 06:18
11/07/23
11/07
06:18
11/07/23
06:18
PRLD

Prelude Therapeutics

$2.93 /

+0.655 (+28.85%)

H.C. Wainwright lowered…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Prelude Therapeutics price target lowered to $3 from $5 at Barclays » 05:47
11/03/23
11/03
05:47
11/03/23
05:47
PRLD

Prelude Therapeutics

$2.22 /

+0.365 (+19.68%)

Barclays analyst Peter…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Prelude Therapeutics updates pipeline 's clinical progress, prioritization » 17:15
11/01/23
11/01
17:15
11/01/23
17:15
PRLD

Prelude Therapeutics

$1.85 /

+0.16 (+9.47%)

Prelude Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Prelude, AbCellera team on precision antibody drug conjugates in oncology » 17:11
11/01/23
11/01
17:11
11/01/23
17:11
PRLD

Prelude Therapeutics

$1.85 /

+0.16 (+9.47%)

, ABCL

AbCellera

$4.13 /

+0.03 (+0.73%)

Prelude Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Earnings
Prelude Therapeutics reports Q3 EPS (45c), consensus (58c) » 17:09
11/01/23
11/01
17:09
11/01/23
17:09
PRLD

Prelude Therapeutics

$1.85 /

+0.16 (+9.47%)

For the three months…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Prelude Therapeutics price target lowered to $6 from $17 at H.C. Wainwright » 06:21
10/19/23
10/19
06:21
10/19/23
06:21
PRLD

Prelude Therapeutics

$2.37 /

-0.25 (-9.54%)

H.C. Wainwright analyst…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Prelude announces multiple clinical, preclinical presentations at AACR-NCI-EORTC » 06:54
10/15/23
10/15
06:54
10/15/23
06:54
PRLD

Prelude Therapeutics

$2.43 /

-0.05 (-2.02%)

Prelude Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Prelude Therapeutics price target lowered to $5 from $7 at Barclays » 05:59
08/04/23
08/04
05:59
08/04/23
05:59
PRLD

Prelude Therapeutics

$3.61 /

-0.14 (-3.73%)

Barclays analyst Peter…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Prelude Therapeutics expects cash to fund operations into 2026 » 08:08
08/03/23
08/03
08:08
08/03/23
08:08
PRLD

Prelude Therapeutics

$3.77 /

+0.04 (+1.07%)

Cash, Cash Equivalents…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Earnings
Prelude Therapeutics reports Q2 EPS (54c), consensus (63c) » 08:08
08/03/23
08/03
08:08
08/03/23
08:08
PRLD

Prelude Therapeutics

$3.77 /

+0.04 (+1.07%)

Kris Vaddi, Ph.D., Chief…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Syndicate
Prelude prices 3.05M shares at $5.75 in underwritten public offering » 07:10
05/18/23
05/18
07:10
05/18/23
07:10
PRLD

Prelude Therapeutics

$6.29 /

-0.31 (-4.70%)

Prelude Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Syndicate
Prelude Therapeutics 3.048M share Spot Secondary priced at $5.75 » 07:07
05/18/23
05/18
07:07
05/18/23
07:07
PRLD

Prelude Therapeutics

$6.29 /

-0.31 (-4.70%)

The deal priced at the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Syndicate
Prelude Therapeutics files to sell $100M in common stock » 16:13
05/17/23
05/17
16:13
05/17/23
16:13
PRLD

Prelude Therapeutics

$6.29 /

-0.31 (-4.70%)

Morgan Stanley is acting…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Earnings
Prelude Therapeutics reports Q1 EPS (58c), consensus (68c) » 08:34
05/08/23
05/08
08:34
05/08/23
08:34
PRLD

Prelude Therapeutics

$6.52 /

+0.42 (+6.89%)

"Our recent…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.